imfinzi - durvalumab injection, solution
(Durvalumab)Astrazeneca Pharmaceuticals Lp
Usage: Imfinzi is a PD-L1 blocking antibody indicated for adults with multiple cancers, including non-small cell lung cancer, small cell lung cancer, biliary tract cancer, hepatocellular carcinoma, endometrial cancer, bladder cancer, and gastric or gastroesophageal junction adenocarcinoma.